HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:DOC • US42250P1030
17 USD
+0.16 (+0.95%)
At close: Feb 10, 2026
17 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
Overall DOC gets a fundamental rating of 3 out of 10. We evaluated DOC against 122 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, DOC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- DOC had positive earnings in the past year.
- DOC had a positive operating cash flow in the past year.
- DOC had positive earnings in each of the past 5 years.
- In the past 5 years DOC always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 0.35%, DOC perfoms like the industry average, outperforming 45.08% of the companies in the same industry.
- DOC's Return On Equity of 0.94% is in line compared to the rest of the industry. DOC outperforms 45.08% of its industry peers.
- The Return On Invested Capital of DOC (2.24%) is comparable to the rest of the industry.
- DOC had an Average Return On Invested Capital over the past 3 years of 2.27%. This is in line with the industry average of 3.07%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- DOC's Profit Margin of 2.50% is in line compared to the rest of the industry. DOC outperforms 45.08% of its industry peers.
- DOC's Profit Margin has declined in the last couple of years.
- DOC has a Operating Margin of 19.31%. This is comparable to the rest of the industry: DOC outperforms 45.90% of its industry peers.
- In the last couple of years the Operating Margin of DOC has grown nicely.
- DOC has a Gross Margin of 60.00%. This is in the lower half of the industry: DOC underperforms 66.39% of its industry peers.
- In the last couple of years the Gross Margin of DOC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
- The number of shares outstanding for DOC has been reduced compared to 1 year ago.
- Compared to 5 years ago, DOC has more shares outstanding
- The debt/assets ratio for DOC is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.33, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- DOC's Altman-Z score of 0.33 is on the low side compared to the rest of the industry. DOC is outperformed by 61.48% of its industry peers.
- DOC has a debt to FCF ratio of 6154.93. This is a negative value and a sign of low solvency as DOC would need 6154.93 years to pay back of all of its debts.
- With a Debt to FCF ratio value of 6154.93, DOC perfoms like the industry average, outperforming 59.84% of the companies in the same industry.
- DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
- DOC's Debt to Equity ratio of 1.27 is in line compared to the rest of the industry. DOC outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Altman-Z | 0.33 |
ROIC/WACC0.38
WACC5.98%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC has a worse Current ratio (0.48) than 81.15% of its industry peers.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- The Quick ratio of DOC (0.48) is worse than 81.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. Growth
3.1 Past
- The earnings per share for DOC have decreased by 0.00% in the last year.
- DOC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.06% yearly.
- DOC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.52%.
- The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
- Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y0.77%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 48.57, DOC can be considered very expensive at the moment.
- DOC's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 28.03, DOC is valued quite expensively.
- A Price/Forward Earnings ratio of 64.38 indicates a quite expensive valuation of DOC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, DOC is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.57 | ||
| Fwd PE | 64.38 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than the industry average as 67.21% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7384.79 | ||
| EV/EBITDA | 13.22 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
5. Dividend
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.18%, which is a nice return.
- Compared to an average industry Dividend Yield of 6.81, DOC pays a bit more dividend than its industry peers.
- DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.18% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- DOC pays out 1204.15% of its income as dividend. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
17
+0.16 (+0.95%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.56%
Market Cap11.82B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts75
Price Target20.27 (19.24%)
Short Float %3.7%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.18% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-2.07%
PT rev (3m)-4.5%
EPS NQ rev (1m)0.81%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-3.17%
Revenue NQ rev (1m)-1.15%
Revenue NQ rev (3m)-1.1%
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.57 | ||
| Fwd PE | 64.38 | ||
| P/S | 4.19 | ||
| P/FCF | 7384.79 | ||
| P/OCF | 9.44 | ||
| P/B | 1.58 | ||
| P/tB | 1.74 | ||
| EV/EBITDA | 13.22 |
EPS(TTM)0.35
EY2.06%
EPS(NY)0.26
Fwd EY1.55%
FCF(TTM)0
FCFY0.01%
OCF(TTM)1.8
OCFY10.6%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | 0.06% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 118.09% | ||
| Cap/Sales | 44.3% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | 2.27% | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.33 |
F-Score6
WACC5.98%
ROIC/WACC0.38
Cap/Depr(3y)91.62%
Cap/Depr(5y)145.43%
Cap/Sales(3y)33.64%
Cap/Sales(5y)52.36%
Profit Quality(3y)87.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year278.7%
EBIT Next 3Y62.79%
EBIT Next 5Y37.45%
FCF growth 1Y-99.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 48.57 and the Price/Book (PB) ratio is 1.58.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.